As a proof-of-concept, we exploited the acidic extracellular pH [32] within the TME and developed an epH-activated DNA nanodevice, termed as pH-CT, to inhibit tumor metastasis by selectively interrupting the relevant signal transduction. The gene discussed is EPHA1; the disease is neoplasm.